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Abstract  45 
Rationale: The major human genes regulating M. tuberculosis (Mtb)-induced immune 46 
responses and tuberculosis (TB) susceptibility are poorly understood. Although IL-12 47 
and IL-10 are critical for TB pathogenesis, the genetic factors that regulate their 48 
expression are unknown. CNBP, REL, and BHLHE40 are master regulators of IL-12 and IL-49 
10 signaling. 50 
Objectives: To determine whether common human genetic variation in CNBP, REL and 51 
BHLHE40 is associated with IL-12 and IL-10 expression, adaptive immune responses to 52 
mycobacteria, and susceptibility to TB. 53 
Methods and Main Measurements: We characterized the association between common 54 
variants in CNBP, REL, and BHLHE40 and innate immune responses in dendritic cells and 55 
monocyte-derived macrophages (MDM), BCG-specific T cell responses, and 56 
susceptibility to pediatric and adult TB. 57 
Results: SNP BHLHE40 rs4496464 was associated with increased BHLHE40 expression in 58 
MDMs and increased IL-10 from both peripheral blood dendritic cells and MDMs after 59 
LPS and TB whole cell lysate stimulation. SNP BHLHE40 rs11130215, in linkage 60 
disequilibrium with rs4496464, was associated with increased BCG-specific IL2+CD4+ T 61 
cell responses and decreased risk for pediatric TB in South Africa. SNPs REL rs842634 62 
and CNBP rs11709852 were associated with increased IL-12 production from dendritic 63 
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cells, and SNP REL rs842618, in linkage disequilibrium with rs842634, was associated 64 
with increased risk for TB meningitis. 65 
Conclusions: Genetic variation in CNBP, REL, and BHLHE40 is associated with IL-12 and 66 
IL-10 cytokine response and TB clinical outcomes. Common human genetic regulation of 67 
well-defined intermediate cellular traits provides insights into mechanisms of TB 68 
pathogenesis. 69 
Abstract Word Count: 240 70 
Keywords: CNBP, REL, BHLHE40, dendritic cells, genetics, M. tuberculosis 71 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)






 Tuberculosis (TB) is a leading cause of death from infection worldwide. The 73 
current BCG vaccine remains the only approved vaccine against TB despite its partial 74 
and variable effects across populations (1). Vaccine efforts are hampered by a lack of 75 
understanding of the immune correlates of protection (2). Understanding the factors 76 
required to induce effective, long lasting immunity to infections may provide tools to 77 
improve TB vaccines.  78 
 79 
 Twin, Mendelian, linkage, genome-wide association, and candidate gene studies 80 
suggest that genetic factors influence susceptibility to TB (3, 4). Multiple clinical TB 81 
phenotypes show a high degree of heritability, including host susceptibility to 82 
pulmonary TB (5-10), TB meningitis (11, 12), and latent TB infection (13-17). However, 83 
the major genes regulating TB susceptibility have not yet been identified with consistent 84 
results across multiple populations, possibly due to heterogeneous clinical phenotypes 85 
and lack of mechanistic correlation of genetic variants with immunophenotypes (3).  To 86 
overcome these obstacles, we evaluated LPS and Mtb whole cell lysate (TBWCL)-induced 87 
cytokine responses from immune cells, followed by clinical correlation, to improve the 88 
power and mechanistic insight of genetic studies.  89 
 90 
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Common genetic variation influences the cellular innate immune response to 91 
Mycobacterium tuberculosis (Mtb). Multiple studies demonstrate the impact of genetic 92 
variation on innate immune cellular distribution and cytokine responses (18-21). 93 
Quantitative trait loci (QTL) of gene expression demonstrate immune cell-specific effects 94 
(22). Recent advances permit the evaluation of innate immune cytokine responses from 95 
rare cell populations (23, 24).  Variants that influence functional responses in immune 96 
cells of interest represent attractive secondary traits which can be correlated with TB 97 
susceptibility and these correlations may provide insight into genetic mechanisms of 98 
disease susceptibility (25). 99 
 100 
Dendritic cells (DCs) present antigen to T cells via MHC Class I and II, co-stimulate 101 
them with CD40 and CD80, and influence T cell differentiation by producing cytokines 102 
like IL-12p70, IL-10, and IL-23, to induce T cell differentiation (26). DCs are essential for 103 
mycobacterial immunity (15, 27) and common genetic variants that influence DC 104 
migration are also associated with TB susceptibility (7).  IL-10 and IL-12 are particularly 105 
important for T cell function in Mtb infection. Individuals with Mendelian deficiencies in 106 
IL-12 signaling rapidly develop serious, disseminated mycobacterial infections (28, 29). 107 
However, the effect of common genetic variation on physiologic levels of IL-10 and IL-108 
12, and the influence of these cytokines on BCG-specific T cell responses and TB 109 
outcomes in humans is not known.  After inflammatory stimulation, the transcription 110 
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factor CNBP and its binding partner c-REL translocate to the nucleus and induce IL12B 111 
transcription, which encodes the IL-12p35 protein subunit (30, 31). Likewise, IL-10 112 
production influences Mtb immune responses, as it diminishes T cell activation, 113 
enhances regulatory T cell activity, and may be responsible for delayed T cell priming 114 
observed in the initial Mtb immune response (32, 33). In mice, the transcription factor 115 
BHLHE40 controls IL-10 production from both myeloid and lymphoid cells, with 116 
contribution from CNBP (30, 31, 34). The role of these genes and their genetic variants in 117 
human regulation of T cell responses is unknown. In this study, we investigated whether 118 
common human genetic variation in the transcription factors CNBP, REL, and BHLHE40 119 
were associated with DC cytokine responses, BCG-specific T cell responses and TB 120 
susceptibility. 121 
 122 
Materials and Methods 123 
Ethics Statement 124 
Approval for human study protocols was obtained from the institutional review boards 125 
at local sites and at the University of Washington School of Medicine (Seattle, WA). The 126 
South African study included written informed consent from the parent or legal 127 
guardian of the participant and approval by the University of Cape Town Research Ethics 128 
Committee. Written informed consent was received from all participants before 129 
inclusion in the study. For genetic studies in Vietnam, approval for human study 130 
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protocols was obtained from the human subjects review boards at the University of 131 
Washington School of Medicine, the Hospital for Tropical Diseases, Pham Ngoc Thach 132 
Hospital, Hung Vuong Hospital, and the Oxford Tropical Research Ethics Committee. 133 
Written informed consent was obtained from patients or their relatives if the patient 134 
could not provide consent. 135 
 136 
Study Participants 137 
Study participants in the Seattle cohort were volunteers self-described as healthy 138 
without history of recurrent serious infections. 52% of individuals were female, and 48% 139 
were male. The ethnic composition of this study group was 69% White, 19% Asian, 2% 140 
Black or African American, and 2% Latinx. Average age of study participants was 39, with 141 
interquartile range of 29 – 46 at the time of their enrollment.  142 
  143 
South African study participants were enrolled at the South African Tuberculosis 144 
Vaccine Initiative field site in Worcester, South Africa, near Cape Town as part of a larger 145 
study on BCG vaccination with 11,680 infants (35, 36). This area has one of the highest 146 
rates of TB in the world with an incidence of 3% among children less than 3 years of age 147 
in the study population (35, 36). A nested genetics case-control study was performed 148 
with identification of cases and controls during a 2-year prospective observation period 149 
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after vaccination at birth. The criteria for detection of TB cases have been described 150 
previously and are summarized in the online supplement (37).  151 
 152 
Study subjects from the Vietnam cohort were described previously and are 153 
summarized here and in detail in the online supplement (12). Subjects with tuberculous 154 
meningitis were recruited from two centers in Ho Chi Minh City, Vietnam: Pham Ngoc 155 
Thach (PNT) Hospital for Tuberculosis and the Hospital for Tropical Diseases (HTD). 156 
Subjects with pulmonary TB were recruited from a network of district TB control units 157 
within Ho Chi Minh City that provide directly observed therapy to TB patients. In 158 
addition, pulmonary TB subjects enrolled were recruited from PNT hospital from 2006 159 
through 2008. Vietnamese population controls were otherwise healthy adults with 160 
primary angle closure glaucoma which have been previously described (38). All case and 161 
control participants were unrelated and greater than 95% were of the Vietnamese Kinh 162 
ethnicity. Previous genetic studies of this population indicate minimal population 163 
substructure (12, 39).  164 
 165 
All statistical analyses are described in the online supplement and were 166 
performed using Stata 14.1 and Prism 8.0 software. The remainder of all experimental 167 
procedures are described in detail in the online supplement. 168 
 169 
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Single cell analysis of cytokine production in peripheral blood DCs   171 
To evaluate genetic regulation of IL-10 and IL-12 production from healthy human 172 
donors, we used flow cytometry to measure the proportion of peripheral blood MHC-173 
II+CD11c+ DCs producing IL-10 and IL-12 after stimulation of whole blood with LPS or 174 
TB whole cell lysate (TBWCL; Figure 1A). LPS (10 ng/ml) and TBWCL (50 µg/ml) both 175 
strongly induced IL-12 (Figure 1B) and IL-10 (Figure 1C) from DCs 24 hours after 176 
stimulation. We also measured cytokine responses to LPS (10 ng/ml) and live BCG (106 177 
CFU/ml) 6 hours after stimulation (Figure 1D). We found that LPS and BCG induced IL-178 
12 6 hours after stimulation in CD11c+ DCs.  However, we did not detect IL-10 above 179 
background levels from DCs after 6 hours of stimulation (data not shown). 180 
 181 
Discovery analysis of genetic associations with IL-12 responses to LPS and TBWCL. 182 
 We next examined whether candidate gene variants were associated with LPS or 183 
TB whole cell lysate- (TBWCL) induced IL-12 in DCs.  We interrogated 4 haplotype-184 
tagging SNPs from CNBP, 6 from REL, and 19 from BHLHE40 in a local cohort of healthy 185 
volunteers (Figure E1). REL SNP rs842634 was associated with increased IL-12 after 186 
TBWCL and LPS stimulation (Figure 2A; p = 0.044, generalized linear model (GLM), 187 
Figure 2B; p = 0.037). CNBP SNP rs11709852 was associated with increased IL-12 188 
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production after TBWCL stimulation, but not LPS stimulation (Figure 2C; p = 0.003; 189 
Figure 2D, p = 0.48). No SNPs from BHLHE40 were associated with IL-12 (Table E2). 190 
 191 
CNBP and REL variants are associated with LPS and BCG-induced IL-12 secretion after 6 192 
hour stimulation in an independent dataset. 193 
 We evaluated the association of our candidate SNPs in a second, independent 194 
cohort with whole blood stimulated with BCG (106 CFU/ml) or LPS (10 ng/ml) for 6 195 
hours, followed by measurement of cytokine responses, as described above. REL SNP 196 
rs842634 was associated with increased IL-12 after BCG infection (Figure 3A; p = 0.046, 197 
generalized linear model) and LPS stimulation (Figure 3B; p = 0.024). CNBP SNP 198 
rs11709852 was associated with a trend toward increased IL-12 after BCG stimulation 199 
(Figure 3C; p = 0.078, Mann-Whitney U-test), and was also associated with increased IL-200 
12 after LPS stimulation early in infection Figure 3D; p = 0.014, Mann-Whitney test).  201 
 202 
BHLHE40 SNP rs4496464 is associated with IL-10 secretion from DCs 203 
 Next, we evaluated for associations between genetic variants in CNBP, REL, and 204 
BHLHE40 with IL-10 production from DCs. BHLHE40 SNP rs4496464 was associated with 205 
increased IL-10 production after TBWCL stimulation (Figure 4A; p = 0.005, generalized 206 
linear model). In contrast, rs4496464 was not associated with IL-10 after LPS stimulation 207 
(Figure 4B, p = 0.18). No CNBP or REL SNPs, including rs11709852 and rs842634, were 208 
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associated with IL-10 expression after TBWCL or LPS stimulation. (Figure 4C – F). 209 
BHLHE40 SNP rs4496464 was not associated with IL-12 expression after stimulation with 210 
either TBWCL or LPS (Figure 4G and Figure 4H). 211 
 212 
Rs4496464 is associated with BHLHE40 mRNA expression in monocyte-derived 213 
macrophages 214 
 We evaluated whether rs4496464 genotypes were associated with BHLHE40 215 
mRNA expression in peripheral blood monocyte-derived macrophages (MDM) from 216 
healthy donors. The uncommon G allele of rs4496464 was associated with increased 217 
BHLHE40 in unstimulated monocytes using a dominant model of inheritance (Figure 5; 218 
p = 0.026, A/A vs (G/A + G/G), Mann-Whitney U-test). No other BHLHE40 SNPs were 219 
associated with expression.  There was no association in LPS stimulated monocytes. 220 
CNBP and REL variants were not associated with their respective transcripts (data not 221 
shown). 222 
 223 
Rs4496464 is associated with IL-10 production in LPS and TBWCL stimulated monocyte-224 
derived macrophages. 225 
 To validate our association between rs496464 and IL-10 expression in DCs, we 226 
measured IL-10 secreted from monocyte-derived macrophages (MDMs) stimulated with 227 
either LPS (50 ng/ml) or TBWCL (25 µg/ml) overnight (Figure 6A, n = 26). The rs4496464 228 
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G allele was associated with increased IL-10 after LPS stimulation (Figure 6B, p = 0.01, 229 
generalized linear model). SNP rs4496464 was also associated with increased IL-10 after 230 
TBWCL (Figure 6C, p = 0.005, generalized linear model). SNP rs4496464 was not 231 
associated with TNF secretion after either LPS (Figure 6D) or TBWCL stimulation (Figure 232 
6E), which suggests that variation in BHLHE40 is associated with IL-10 production 233 
specifically, over proinflammatory cytokine responses. 234 
 235 
A genetic marker for REL rs842634 is associated with an increased risk for TB meningitis. 236 
 Our data suggests that rs842634 and rs11709852 are associated with increased 237 
IL-12 in DCs and rs4496464 is associated with increased IL-10 production from 238 
peripheral blood monocytes and DCs in our local population. We hypothesized that 239 
these polymorphisms are associated with susceptibility to TB due to their influence on 240 
these critical immune phenotypes. Within a large genome wide association study 241 
comparing Vietnamese individuals with adult pulmonary TB (PTB; n =1598) or TB 242 
meningitis (TBM; N = 407) with control subjects (N = 1139), we evaluated if SNPs in  243 
CNBP, REL, and BHLHE40 were associated with adult PTB or TBM and in LD with our 244 
SNPs of interest (Figure E2). Although REL rs842634 was not associated with TBM, it was 245 
in moderate to high LD with rs842618 in the Seattle cohort (R2 0.69, D’ 1.0) as well as in 246 
the Vietnamese population (R2 0.39, D’ 1.0). The minor allele of REL SNP rs842618 was 247 
associated with an increased risk for TBM (p = 0.03; OR 1.27, allelic model, Table 1 and 248 
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Table E3). These data best fit a dominant model (Table 1, p = 0.035, OR 1.32, 95% CI 249 
1.02 – 1.73) No BHLHE40 or CNBP SNPs were associated with TBM, including rs4496464 250 
and rs11709852. We did not identify any associations between SNPs in REL, CNBP, or 251 
BHLHE40 SNPs with PTB  (Table E4).  Together, these data suggest that a causal REL 252 
SNP linked to rs842634 and rs842618 is associated with both increased IL-12 production 253 
and increased risk of adult TBM in Vietnam. 254 
 255 
BHLHE40 variants are associated with pediatric TB in South Africa. 256 
We next evaluated whether variants in CNBP, REL, and BHLHE40 were associated with 257 
pediatric TB in South Africa (Figure E3) (40).  BHLHE40 SNP rs11130215 was associated 258 
with decreased risk for pediatric TB in an allelic model (Table 2 and Table E5; p = 0.001) 259 
which best fit a dominant model of inheritance p = 3.3x10-4, OR 0.5 (0.33 – 0.75). 260 
Rs11130215 was in low LD with rs4496464 in the South African cohort (R2 0.10, D’ 0.30). 261 
To adjust for ethnic heterogeneity, we genotyped a panel of 95 ancestry informational 262 
markers (AIMs) and performed principal components analysis, as described previously 263 
(37). The association between rs11130215 and pediatric TB remained statistically 264 
significant after adjustment for gender and the top five principal components of the 265 
tested AIMs (Table 2, p = 0.01, OR 0.24 - 0.83). No REL or CNBP SNPs were associated 266 
with pediatric TB, including rs842634 and rs11709852. Together, these data suggest that 267 
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a BHLHE40 polymorphism (rs11130215) linked to rs4496464 and increased IL-10 268 
expression is associated with a decreased risk for pediatric TB. 269 
 270 
 CREL, CNBP and BHLHE40 SNPs are not associated with BCG-induced T cell responses in 271 
South African infants.  272 
 We next examined whether these variants were associated with adaptive immune 273 
responses as a possible mechanism of TB susceptibility due to DC regulation of T cell 274 
responses. We tested this hypothesis in a cohort of South African infants that were 275 
vaccinated with BCG at birth and whose BCG-specific CD4+ IL-2, TNF, and IFNγ+T cell 276 
responses were measured at 10 weeks of age by flow cytometry (36, 37) (Figure E4). 277 
Overall media (Figure 7A), BCG-induced (Figure 7B), and SEB-induced (Figure 7C) 278 
responses are shown. We evaluated the association between genetic variation in our 279 
SNPs of interest: rs842634, rs11709852, rs4496464, and rs11130215, with the frequency 280 
of BCG-induced IL-2, TNF, and IFNγ in CD4+ T-cells. Rs11709852 and rs842634 were 281 
monoallelic in the South African cohort and not analyzed further. Rs4496464 was 282 
associated with a trend toward increased IL2+CD4+ T cell frequency after BCG re-283 
stimulation but this did not achieve statistical significance (Figure 7D, p = 0.15, 284 
generalized linear model). This SNP was not associated with TNF or IFNγ frequency in 285 
CD4+ T cells (Figure  7E-F). The G allele of BHLHE40 rs11130215 was associated with 286 
increased frequency of BCG-specific IL2+CD4+ cells (Figure 7G, p = 0.015, generalized 287 
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linear model), but not TNF or IFNγ (Figure 7H-I). In a second validation cohort, 288 
rs11130215 was associated with a trend toward increased IL-2 expression that did not 289 
achieve statistical significance (Figure 7J, p = 0.06, generalized linear model). However, 290 
when these data were combined, we found that this SNP was associated with increased 291 
IL-2 from CD4+ T cells (Figure 7K, p = 0.006, generalized linear model).  Taken together, 292 
these data suggest that a BHLHE40 variant is associated with increased IL-2-producing 293 
CD4+ T cells, and decreased risk for pediatric TB in a genetic cohort of South African 294 
infants.  295 
 296 
Discussion 297 
IL-12 and IL-10 are both essential for an effective host response to tuberculosis, 298 
and overexpression of either cytokine can similarly lead to adverse outcomes. In this 299 
paper, we found that variation in REL and BHLHE40, genes that directly influence 300 
expression of these cytokines, is associated with secretion of IL-12 and IL-10, 301 
respectively, from peripheral blood DCs using a flow cytometry-based assay. To our 302 
knowledge, this assay has not been used previously to evaluate the genetics of DC 303 
immune responses (20, 41). Related variants in REL were associated with increased 304 
expression of IL-12 and also with increased susceptibility to TBM, and SNPs in BHLHE40 305 
associated with increased IL-10 were also associated with decreased risk for pediatric TB. 306 
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These data represent the most comprehensive evaluation of the human genetic loci 307 
associated with IL-10 and IL-12 production in TB pathogenesis.  308 
 309 
 Both insufficient and excessive IL-10 responses are harmful to TB control (32, 42). 310 
We found BHLHE40 variants that were associated with increased IL-10 production in 311 
myeloid cells after LPS and TB whole cell lysate stimulation. A variant in linkage 312 
disequilibrium was also associated with increased BCG-specific IL-2+CD4+ T cells with 313 
stable frequencies of TNF+ and IFNγ+ CD4+ T cells in South African infants. Critically, 314 
this variant was associated with decreased risk for developing pediatric TB. Canonically, 315 
increased IL-10 is associated with increased differentiation of regulatory T cells (43), 316 
which may delay the appropriate activation of effective adaptive immune responses to 317 
Mtb (44). However, a balanced immune response with increased number of antigen-318 
specific T cells overall is beneficial to preventing infection. The relatively modest 319 
changes to the cytokine response associated with genotype may influence T cell 320 
proliferation and differentiation to promote a balanced and effective T cell response 321 
(45). Moreover, BHLHE40 also demonstrates direct effects on T cell function in murine 322 
models, and may be an alternate mechanism for the phenotypes we observed (46). IL-10 323 
decreases pathology that may promote effective Mtb control (34, 47). Our observations 324 
are consistent with a model whereby modest increases in BHLHE40 are associated with 325 
increased IL-10 in macrophages, expanded IL-2+CD4+ T cell responses, and protection 326 
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from TB. Notably, these data support findings from the mouse model, where BHLHE40 327 
deficiency was associated with early Mtb death due to excessive neutrophil-dominant 328 
inflammatory response (34). Study of the factors that influence IL-10 expression may 329 
provide insight into a suite of macrophage or T cell changes that may provide insight 330 
into TB susceptibility and control. 331 
 332 
 Variation in REL rs842634 was associated with increased IL-12 production from 333 
dendritic cells after LPS and TBWCL stimulation. A SNP in linkage disequilibrium, 334 
rs842618, was also associated with increased risk for TB meningitis in a Vietnamese 335 
cohort. Although IL-12 is canonically associated with protection from TB, significant 336 
evidence has accumulated that increases in proinflammatory cytokines, including TNF 337 
and IFNγ, may also be harmful for Mtb control in some settings, including TBM (12, 45, 338 
48).  Although IL-12α and IFNγ are essential for control of Mtb infection, the amount 339 
necessary for protection remains unclear (45). Excessive IFNγ induces immune pathology 340 
requiring anti-inflammatory therapy during TB immune reconstitution syndrome (49). IL-341 
12 also induces TNF, in CD4+ T cells as part of the Th1 response (50). Excess TNF in 342 
Mtb-infected macrophages leads to necrosis and Mtb spread, and worsens TBM 343 
outcomes (51). Identification of genetic factors that modulate dendritic cell 344 
proinflammatory cytokines provides insight into the optimal balance of cytokines to 345 
control Mtb in adults. 346 
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This study has several potential limitations. We do not yet have evidence of 348 
functional SNPs that directly regulate gene function. Future fine-mapping studies with in 349 
vitro mechanistic assays will be required to determine the specific alleles that regulate 350 
cellular function and clinical outcomes together. A second limitation is that some of 351 
these observations do not achieve statistical significance after adjustments for multiple 352 
comparisons with associations with clinical outcomes.  Although this limitation is true for 353 
the clinical findings, the evidence supporting a genetic regulatory role of human cellular 354 
IL12/IL10 responses was robust and provided support for the possible clinical 355 
associations.  Given this, we used a threshold of p < 0.05 as a measure of statistical 356 
significance, without the conservative Bonferroni correction. Further studies will be 357 
needed in additional cohorts, particularly after discovery of the causal SNP that 358 
regulates cytokine production. Third, case-control studies of TB outcomes may have 359 
misclassification of controls, as we examined population controls in studies in our 360 
Vietnamese cohort. However, classification errors that arise from such control 361 
populations likely lead to reduction in the statistical power of these studies.  362 
 363 
To our knowledge, this study represents the most comprehensive analysis to date 364 
of genetic regulation of dendritic cell IL-12 and IL-10 production by common 365 
polymorphisms and their association with TB outcomes. Although further studies are 366 
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required, overlapping genetic studies of immune outcomes and TB clinical susceptibility 367 
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Figure Legends 378 
Figure 1. IL-10 and IL-12 responses in peripheral blood DCs in whole blood 379 
stimulation assay 380 
Peripheral whole blood was obtained from healthy volunteers and stimulated with either 381 
negative control or immune stimuli followed by BFA and monensin 2 hours afterward. 382 
Afterward cells were fixed and frozen. At the time of staining, samples were thawed in 383 
large batches to minimize batch effects. A) Gating strategy. From left to right, singlets 384 
were selected, then leukocytes.  CD66+ cells were gated out, and the HLA-DR+ 385 
population selected. CD14- and CD16- and CD11c+ cell population was selected and 386 
the proportion of cytokine positive cells were measured as compared to total number of 387 
HLA-DR+CD11c+ DCs.  388 
B) Proportion of IL-12+CD11c+ DCs after media control, LPS (10 ng/ml), or Mtb whole 389 
cell lysate (TBWCL; 50 µg/ml) stimulation for 24 hours.  390 
C) Proportion of IL-10+CD11C+ DCs after media, LPS, or TBWCL for 24 hours.  391 
D) Proportion of IL-12+CD11c+ DCs after media, LPS, or live BCG (106 CFU) stimulation 392 
for 6 hours. Bars demonstrate median values. Data provided are not corrected for 393 
background cytokine positivity. Dots represent individual values. N = 46. 394 
 395 
Figure 2. REL SNP rs842634 and CNBP SNP rs11798052 are associated with IL-12 396 
production after TBWCL stimulation of peripheral blood DCs for 24 hours 397 
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A-B) Proportion of CD11c+ DCs producing IL-12 after A) Mtb whole cell lysate (TBWCL; 398 
50 µg/ml) stimulation or B) LPS (10 ng/ml) stimulation for 24 hours. Data are stratified 399 
by rs842634 genotype; N = 19 T/T, 21 T/C, and 7 C/C. 400 
C-D) Proportion of CD11c+ DCs producing IL-12 after C) TBWCL or D) LPS stimulation 401 
for 24 hours. Data are stratified by rs11798052 genotype; N = 34 G/G, 5 G/A, and 2 A/A. 402 
All data presented in this figure and afterward represent background-corrected values 403 
(proportion of cytokine-producing cells after ligand stimulation – proportion of 404 
cytokine-producing cells after media control stimulation). 405 
* p < 0.05; statistical significance determined by generalized linear model. 406 
 407 
Figure 3. REL SNP rs842634 is associated with IL-12 production in peripheral blood 408 
DCs after 6 hours of BCG or LPS stimulation  409 
A-B) Proportion of CD11c+ DCs producing IL-12 after A) live BCG stimulation (106 CFU) 410 
or B) LPS (10 ng/ml) stimulation for 6 hours. Data are stratified by rs842634 genotype; N 411 
= 15 T/T, 16 T/C, and 4 C/C.  412 
C-D) Proportion of CD11c+ DCs producing IL-12 after C) live BCG stimulation or D) LPS 413 
stimulation for 6 hours. Data are stratified by rs11798052 genotype; N = 31 G/G, 5 G/A. 414 
* p < 0.05; ** p < 0.01, *** p < 0.001; statistical significance determined by generalized 415 
linear model for A-B and Mann-Whitney U-test for C-D. 416 
 417 
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Figure 4. BHLHE40 SNP rs4496464 is associated with IL-10 production from 418 
peripheral blood DCs after Mtb whole cell lysate stimulation  419 
A-B) Proportion of CD11c+ DCs producing IL-10 after A) Mtb whole cell lysate (TBWCL; 420 
50 µg/ml) or B) LPS (10 ng/ml) stimulation for 24 hours. Data are stratified by rs4496494 421 
genotype; N = 40 A/A, 7 G/A and 2 G/G.  422 
C-D) Proportion of CD11c+ DCs producing IL-10 after C) LPS or D) TBWCL stimulation 423 
for 24 hours. Data are stratified by rs11798052 genotype; N = 33 G/G, 5 G/A, and 2 A/A.  424 
E-F) Proportion of CD11c+ DCs producing IL-10 after E) LPS or F) TBWCL stimulation for 425 
24 hours. Data are stratified by rs842634 genotype; n = 19 T/T genotype, 21 T/C 426 
genotype, and 7 C/C genotype.  427 
G-H) Proportion of CD11c+ DCs producing IL-12 after E) TBWCL or F) LPS stimulation 428 
for 24 hours. Data are stratified by rs4496494 genotype. N = 38 A/A, 7 G/A, 2 G/G.  429 
* p < 0.05; ** p < 0.01, *** p < 0.001; generalized linear model. 430 
 431 
Figure 5. BHLHE40 SNP rs4496464 is associated with increased BHLHE40 mRNA 432 
expression in monocyte-derived macrophages  433 
BHLHE40 mRNA expression, normalized to GAPDH expression, was measured from RNA 434 
extracted from MDMs isolated from healthy volunteers and stratified by rs4496464; n = 435 
26 A/A, 7 G/A, and 1 G/G. * p < 0.05; dominant genetic model. 436 
 437 
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Figure 6. BHLHE40 SNP rs4496464 is associated with IL-10 production from 438 
monocyte-derived macrophages 439 
Peripheral blood monocytes were differentiated into macrophages by M-CSF for 5 days, 440 
then stimulated with either LPS (50 ng/ml) or Mtb whole cell lysate (TBWCL; 25 µg/ml).  441 
A) Overall IL-10 cytokine concentrations from cellular supernatants MDMs after 24 hours 442 
of stimulation.  443 
B-C) Concentration of IL-10 in cellular supernatants after B) LPS stimulation or C) TBWCL 444 
stimulation for 24 hours, stratified by rs4496494 genotype. N = 20 A/A, 6 G/A, 2 G/G.  445 
D-E) Concentration of TNF in cellular supernatants after D) LPS stimulation or E) TBWCL 446 
stimulation for 24 hours and stratified by rs4496464. 447 
* P < 0.05, ** P < 0.01, *** P < 0.001; generalized linear model. 448 
 449 
Figure 7. BHLHE40 SNP rs11130215 is associated with BCG-induced IL-2+CD4+ T-450 
cell responses in South African infants  451 
BCG-specific CD4+ T cell responses from South African infants at 10 weeks of age were 452 
measured by flow cytometry and stratified by genotype of interest. Background 453 
correction was performed by subtracting the proportion of cytokine-producing cells 454 
after BCG or SEB stimulation from media control stimulation. 455 
A-C) A) Media control, B) BCG-induced, and C) staphylococcus enterotoxin B (SEB)-456 
induced IL-2, TNF, and IFNγ+ CD4+ T cell responses. N = 88. 457 
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D-F) We measured the frequency of BCG-specific D) IL-2+, E) TNF+, and F) IFNγ+ CD4+ 458 
T cells after 12 hours of re-stimulation and stratified by rs4496464. A/A N = 29, G/A N = 459 
44, G/G N = 11. 460 
G-I) We measured the frequency of BCG-specific G) IL-2+, H) TNF+, and I) IFNγ+ CD4+ T 461 
cells after 12 hours of re-stimulation and stratified by rs11130215 in a discovery cohort. 462 
A/A N = 24, G/A N = 31, G/G N = 19. 463 
J) Proportion of BCG-specific IL-2+CD4+ T cells, stratified by rs11130215, in an 464 
independent validation set. A/A N = 26, G/A N = 47, G/G N = 20. 465 
K) Combined datasets from D) and I). 466 
All data visualized as Tukey plots, with middle bar representing median, thick bars with 467 
interquartile range, and whiskers drawn to 10-90th percentile. Outliers are represented 468 
with dots. * p < 0.05, ** p < 0.01, generalized linear model. 469 
 470 
  471 
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Table 1. Association of REL SNPs with adult TB meningitis in Vietnam. Number of 472 
individuals with major homozygous (AA), heterozygous (Aa), and minor homozygous 473 
(aa) genotypes described. Total: total N in group after genotyping. Allelic p: p value in 474 
an allelic genetic model. Dom p: p value in a dominant genetic model of inheritance. OR: 475 
odds ratio in an allelic genetic model. CI: confidence interval. 476 
 477 
  Control  Case     
locus Gene AA Aa aa Total AA Aa aa Total Allelic p Dom p 
OR 
(95% CI) 
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Table 2. Association of SNPs with pediatric TB in South Africa.  Number of 480 
individuals with major homozygous (AA), heterozygous (Aa), and minor homozygous 481 
(aa) genotypes described.  Allelic p: p value in an allelic genetic model. Dom p: p value in 482 
a dominant genetic model by logistic regression with adjustment for ancestry and 483 
gender. OR: odds ratio; CI: confidence interval. * adjusted for ethnicity and gender by 484 
logistic regression.  485 
  Control  Case     
locus Gene AA Aa aa Total AA Aa aa Total 
Allelic 
p Dom p 
OR (95% 
CI) 
rs11130215 BHLHE40 99 169 65 333 78 67 25 170 0.001 3.3x10-4 
0.5 (0.33 – 
0.75 
           0.012* 
0.56 (0.28 
-0.87)* 
rs4496464 BHLHE40 158 141 35 334 86 66 17 169 0.51 0.48 
1.21 (0.72-
2.0) 
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